Click below to hear recorded Q&A audio for each question from our live webcast audience.
Could whole-blood assays be used to detect cell-mediated responses to SARS-CoV-2 infection, to avoid PBMC isolation?
Is there any evidence that people who don’t produce antibodies are producing T cell responses to SARS-CoV-2?
Are you seeking EUA for the test?
We are seeing very sick patients who often have profound lymphopenia. How does this affect the T-SPOT® Discovery™ test?
We have a question about the size and number of peptides.
How do we know if the T cells in the assay are SARS-CoV-2 specific? Could they be responding to another human coronavirus?
T-SPOT is a registered trademark of Oxford Immunotec Ltd.
About our Speaker
Ruth Brignall, PhD
Ruth Brignall is a Medical Science Liaison for Oxford Immunotec. Dr. Brignall has a PhD in Immunology and Cell Biology from the University of Manchester, UK where her studies focused on adaptive immune responses, and developing a quantitative, single-cell understanding of T cell activation.
Thank you for watching this on-demand webinar.
Oxford Immunotec is committed to providing medical education on an on-going basis.
If you have a suggested topic of interest please email: Ondemandeducation@oxfordimmunotec.com